1 Global Portable Oxygen Concentrators Market Size (Value) and CAGR (2024-2033)
In 2024, the global Portable Oxygen Concentrators market was valued at USD 1497.25 million, with a CAGR of 12.9% from 2024 to 2033.
Portable Oxygen Concentrators refers to a device that produces oxygen through some technologies to provide oxygen to users. Such as molecular sieve, electrolytic oxygen production, polymer oxygen permeable membrane oxygen production, chemical oxygen production and other methods. The main advantage of Portable Oxygen Concentrators is that no oxygen storage equipment and fixed oxygen source are needed. For example, when continuous oxygen supply is required, the cost is lower, which is more convenient for people who continue to inhale oxygen.
Figure Global Portable Oxygen Concentrators Market Size (M USD) and CAGR 2024-2033
2 Portable Oxygen Concentrators Market Drivers
The market for Portable Oxygen Concentrators (POCs) is experiencing significant growth, driven by several key opportunities and drivers. One of the primary drivers is the increasing prevalence of respiratory diseases such as sleep apnea, asthma, and chronic obstructive pulmonary disease (COPD). According to the American Sleep Association, an estimated 50 to 70 million people in the United States suffer from some form of sleep disorder.
Similarly, the Canadian Respiratory Journal reports that approximately 5.4 million adults in Canada have been diagnosed with sleep apnea or are at higher risk of developing it. In Europe, ResMed’s research indicates that about 175 million people suffer from sleep apnea. Asthma, another prevalent respiratory condition, affected 262 million people globally in 2019, causing 461,000 deaths, as reported by the World Health Organization. The need for effective oxygen therapy to manage these conditions has significantly boosted the demand for POCs.
Another significant driver is the aging global population. The United Nations’ “World Population Outlook” report projects that by 2050, one-sixth of the world’s population will be over 65 years old. Regions such as Asia and Europe are particularly affected, with Japan having the highest proportion of people aged 65 and over at 28%, followed by Italy at 23%. The elderly are more susceptible to chronic diseases, and conditions such as sleep apnea, anemia, and post-surgical recovery often necessitate oxygen therapy. POCs offer a convenient and portable solution for elderly individuals with low blood oxygen levels, making them an essential tool in geriatric care.
3 Portable Oxygen Concentrators Market Restraints
Despite the significant growth opportunities, the Portable Oxygen Concentrators (POCs) market also faces several challenges. One of the primary challenges is the strict regulatory environment. The use of POCs on aircraft, for example, is subject to stringent certification requirements. Airlines often only accept POCs certified by the US Federal Aviation Administration (FAA), which conducts electronic equipment interference testing and authorization. This regulatory complexity can pose significant hurdles for manufacturers, limiting market entry and product availability.
Another major challenge is the high cost of POCs, which translates into higher prices for consumers. Unlike traditional oxygen tanks, which are a one-time investment, POCs are more expensive due to their advanced technology and manufacturing processes. In countries like India, the cost of POCs has been exacerbated by rising commodity prices for steel and plastics, essential materials for manufacturing.
4 Global Portable Oxygen Concentrators Market Size and Share by Type in 2024
Molecular Sieve Oxygen Concentrators are the most prevalent type in the market. These devices use the Pressure Swing Adsorption (PSA) method to separate oxygen from air. The molecular sieve, typically made of zeolite, adsorbs nitrogen from the air, allowing oxygen to be concentrated and delivered to the user. In 2024, the market value for Molecular Sieve Oxygen Concentrators was 1,094.37 million USD. This type is highly favored due to its efficiency, reliability, and ability to provide a continuous supply of high-purity oxygen. It is particularly useful for medical applications where a stable and high concentration of oxygen is required.
Macromolecule Oxygen Permeable Membrane Oxygen Concentrators utilize polymer membranes to separate oxygen from air. These membranes allow oxygen molecules to pass through preferentially, resulting in a high concentration of oxygen. In 2024, this segment had a market value of 62.30 million USD. These devices are known for their compact design and ease of use, making them suitable for both medical and household applications. They are particularly beneficial for patients who require a portable and lightweight solution for their oxygen needs.
Electrolysis Oxygen Concentrators generate oxygen through the process of electrolysis, where water is split into hydrogen and oxygen using an electric current. This method is highly efficient and produces pure oxygen. In 2024, the market value for Electrolysis Oxygen Concentrators was 236.19 million USD. These devices are often used in medical settings and are known for their reliability and high output. They are particularly useful in environments where a continuous and high volume of oxygen is required, such as hospitals and long-term care facilities.
Table Global Portable Oxygen Concentrators Market Size and Share by Type in 2024
Type | Market Size (M USD) 2024 | Market Share 2024 |
Molecular Sieve Oxygen Concentrator | 1094.37 | 73.09% |
Macromolecule Oxygen Permeable Membrane Oxygen Concentrator | 62.30 | 4.16% |
Electrolysis Oxygen Concentrator | 236.19 | 15.78% |
Chemical Oxygen Concentrator | 35.72 | 2.39% |
Other | 68.67 | 4.59% |
Total | 1497.25 |
5 Global Portable Oxygen Concentrators Market Sales (K Units) by Application in 2024
Medical applications of POCs are primarily used in healthcare settings such as hospitals, clinics, and long-term care facilities. These devices are essential for patients with chronic respiratory conditions, post-surgical care, and emergency situations. In 2024, the sales volume for medical applications was 162.07 thousand units. The demand for POCs in medical settings is driven by the need for reliable and high-purity oxygen supply, especially in critical care units and emergency departments.
Household applications of POCs are designed for personal use at home. These devices are particularly beneficial for individuals with chronic respiratory diseases who require continuous oxygen therapy. In 2024, the sales volume for household applications was 669.98 thousand units. The growth in this segment is driven by the increasing prevalence of respiratory diseases and the aging population, which necessitates the need for convenient and portable oxygen solutions at home.
Table Global Portable Oxygen Concentrators Market Sales (K Units) by Application in 2024
Application | Market Sales (K Units) 2024 | Market Share 2024 |
Medical | 162.07 | 18.23% |
Household | 669.98 | 75.36% |
Other | 56.99 | 6.41% |
6 Global Portable Oxygen Concentrators Market Size by Region in 2024
North America is the largest market for Portable Oxygen Concentrators, driven by the high prevalence of respiratory diseases and the advanced healthcare infrastructure. In 2024, the market value in North America was 611.82 million USD. The United States and Canada are the primary markets, with significant demand from both medical and household applications. The growth in this region is supported by continuous technological advancements and strong consumer awareness of respiratory health.
Europe is the second-largest market, with a significant demand for POCs driven by the aging population and the high prevalence of chronic respiratory conditions. In 2024, the market value in Europe was 435.98 million USD. Countries such as Germany, the UK, France, and Italy are major contributors to the market. The growth in this region is supported by strong healthcare policies and the adoption of advanced medical technologies.
The Asia-Pacific region is experiencing rapid growth in the Portable Oxygen Concentrators market, driven by the increasing prevalence of respiratory diseases and the growing healthcare market. In 2024, the market value in the Asia-Pacific region was 350.27 million USD. China, Japan, South Korea, and India are the primary markets, with significant potential for growth due to the large population and increasing healthcare expenditure. The region’s growth is also supported by the adoption of advanced technologies and increasing consumer awareness of respiratory health.
Figure Global Portable Oxygen Concentrators Market Size by Region in 2024
7 Major Players in Global Portable Oxygen Concentrators Market
7.1 Philips
Company Profile: Philips is a global leader in health technology, founded in 1891 and headquartered in the Netherlands. The company operates worldwide, providing a wide range of healthcare solutions, including diagnostic imaging, image-guided therapy, patient monitoring, and respiratory care products.
Business Overview: Philips focuses on creating integrated health solutions that improve people’s lives through meaningful innovation. Their products and services are designed to enhance the health continuum from healthy living and prevention to diagnosis, treatment, and home care. Philips’ commitment to innovation and sustainability drives their mission to improve the lives of 2 billion people a year by 2030.
Product Offered: Philips offers a variety of portable oxygen concentrators, including the SimplyGo Mini. This device is lightweight and easy to use, providing up to 9 hours of freedom of movement with an extended battery. It features five different pulse dose settings and an easy-to-read LCD touch screen, making it suitable for both medical and household applications.
Recent Financial Performance: In 2021, Philips’ portable oxygen concentrators generated a revenue of 208.30 million USD with a gross margin of 46.74%.
7.2 Inogen
Company Profile: Inogen, founded in 2001 and headquartered in the United States, is a leading provider of innovative respiratory products designed for home care environments. The company is committed to improving the health and independence of patients through reliable and high-quality products.
Business Overview: Inogen’s mission is to enhance the quality of life for individuals with respiratory conditions by providing effective and portable oxygen therapy solutions. Their products are designed to meet the needs of patients requiring supplemental oxygen, offering both medical and household applications. Inogen maintains a strong focus on customer satisfaction and compliance with regulatory standards.
Product Offered: Inogen’s flagship product is the Inogen One G4, which is the company’s lightest and smallest portable oxygen concentrator. This device is designed for patients on lower oxygen prescriptions and features a reliable pulse-based delivery system. It offers up to 5 hours of battery life at the lowest flow setting and meets FAA requirements for air travel.
Recent Financial Performance: In 2021, Inogen’s portable oxygen concentrators achieved a revenue of 241.48 million USD with a gross margin of 45.44%.
7.3 Resmed
Company Profile: Resmed, established in 1989 and headquartered in Australia, is a global leader in digital health solutions, focusing on sleep and respiratory care. The company’s innovative products and services are designed to improve patient outcomes and enhance the quality of life for individuals with respiratory conditions.
Business Overview: Resmed’s mission is to change lives with every breath by providing advanced technologies and solutions for sleep apnea, chronic obstructive pulmonary disease, and other respiratory disorders. Their products are used in both medical and home care settings, offering a range of respiratory therapies and monitoring solutions. Resmed is committed to continuous innovation and maintaining high standards of quality and compliance.
Product Offered: Resmed offers the Mobi portable oxygen concentrator, which is designed for users requiring respiratory therapy. This device features a compact and portable design, long battery life, and a user-friendly interface. It includes multiple battery options and is approved by the Federal Aviation Administration for use on commercial flights.
Recent Financial Performance: In 2021, Resmed’s portable oxygen concentrators generated a revenue of 92.40 million USD with a gross margin of 47.07%.